Is It Better to Treat TH Symptom Than Cures Heps?

A company at theces o, the gilead or cananta forgive i don't know which one it was, came up with a drug that cured heps. Happetite to see cured. The stock took off, but then quickly people realize, well, there's only 80 thousand people in the us. With heps. They'll cure it. It doesn't address te symptoms where youw can have a cash flow for the life of the patient. And so golman sacks and a couple o other research houses wrote that as a business model, it's better to a treat th symptom than cure it,. Because you get a sustainable cash flow. There you go. But that